Opioid abuse initiates specific protein interactions in neurons in brain's reward system

February 24, 2014, The Mount Sinai Hospital

Identifying the specific pathways that promote opioid addiction, pain relief, and tolerance are crucial for developing more effective and less dangerous analgesics, as well as developing new treatments for addiction. Now, new research from the Icahn School of Medicine at Mount Sinai reveals that opiate use alters the activity of a specific protein needed for the normal functioning of the brain's reward center.

Investigators were able to block the protein, as well as increase its expression in the mouse nucleus accumbens, a key component of the brain's reward center. It altered the actions of opioids like morphine dramatically. The preclinical study, published online Feb. 24 in the journal Neuropsychopharmacology, is the first to show that opioid use changes activity of the protein RGS9-2 and alters both the threshold for and affects opioid tolerance.

"We were able to block addiction-related behaviors, but increasing the activity of the protein also lowered the pain relief response to morphine, and mice developed morphine tolerance much more quickly," said the study's senior researcher, Venetia Zachariou, PhD, Associate Professor, Fishberg Department of Neuroscience, Friedman Brain Institute, Department of Pharmacology and Systems Therapeutics, at the Icahn School of Medicine at Mount Sinai.

Dr. Zachariou explained that because the brain's reward center has such a strong impact on analgesic responses, non-opioid medications should be used for the treatment of severe chronic pain conditions. Pain specialists have several alternatives for the treatment of chronic pain. For patients that are already addicted to opioids, "an alternative pain medication could offer more analgesic relief without the adverse effects of opioids." Additionally, with this research in hand, the research team points out that targeting this molecule may eventually lead to a novel treatment for addiction."

In the study, investigators used a novel technique known as optogenetics, which allows the activation of specific neurons via blue light in real time, to determine the exact cell types of the brain reward center responsible for the reduced analgesic response.

"In our earlier work, by inactivating RGS9-2, we saw a tenfold increase in sensitivity to the rewarding actions of morphine, severe morphine dependence, a better analgesic response, and delayed development of tolerance," said the study's senior author. While opiate analgesics act in several brain regions to alleviate pain, their actions in the brain may also affect analgesia. The nucleus accumbens may also affect the development of , via mechanism that are distinct from those described in other regions of the brain.

Eric Nestler, MD, PhD, Nash Family Professor of Neuroscience, Icahn School of Medicine at Mount Sinai, praised the research. "These discoveries provide important new information about the role of the pathway in the analgesic responses to opiates".

Explore further: Opioid tolerance and pain hypersensitivity associated with mTOR activation

Related Stories

Opioid tolerance and pain hypersensitivity associated with mTOR activation

January 2, 2014
Currently, opioids are the standard treatment for chronic pain. Patients on opioids for long periods of time become desensitized to these drugs or become paradoxically hypersensitive to pain (hyperalgesia); however, the adaptive ...

Researcher finds method to improve morphine's effect on managing pain

October 4, 2013
A method to prevent the body from developing tolerance to morphine, a powerful and commonly used pain medication, has been discovered by a Georgia State University researcher.

Promising new drug targets for cocaine addiction found

January 20, 2014
Researchers from the Icahn School of Medicine at Mount Sinai have identified a new molecular mechanism by which cocaine alters the brain's reward circuits and causes addiction. Published online in the journal Proceedings ...

Chemical compound shows promise as alternative to opioid pain relievers

July 15, 2013
A drug targeting a protein complex containing two different types of opioid receptors may be an effective alternative to morphine and other opioid pain medications, without any of the side effects or risk of dependence, according ...

Missing enzyme linked to drug addiction

June 17, 2013
A missing brain enzyme increases concentrations of a protein related to pain-killer addiction, according to an animal study. The results will be presented Monday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Scientists can now block heroin, morphine addiction; clinical trials possible within 18 months

August 14, 2012
In a major breakthrough, an international team of scientists has proven that addiction to morphine and heroin can be blocked, while at the same time increasing pain relief.

Recommended for you

Observing brain plasticity during cello training

June 15, 2018
Music acquisition provides an excellent model of neural plasticity, and has become a hot research subject in neurology. Music performance provides an unmatched array of neural complexities revealing how neural networks are ...

New discovery about the brain's water system may prove beneficial in stroke

June 15, 2018
Water is transported from the blood into the brain via an ion transporter, according to a new study on mice conducted at the University of Copenhagen. If the mechanism can be targeted with medicine, it may prove relevant ...

When emotional memories intrude, focusing on context could help, study finds

June 14, 2018
When negative memories intrude, focusing on the contextual details of the incident rather than the emotional fallout could help minimize cognitive disruption and redirect the brain's resources to the task at hand, suggests ...

The neurons that rewrite traumatic memories

June 14, 2018
Memories of traumatic experiences can lead to mental health issues such as post-traumatic stress disorder (PTSD), which can destroy a person's life. It is currently estimated that almost a third of all people will suffer ...

Researchers find transport molecule has unexpected role

June 14, 2018
UT Southwestern researchers recently reported a basic science finding that might someday lead to better treatments for neurodegenerative diseases like a hereditary form of Lou Gehrig's disease.

Neuroscientists locate neurons in the brain that respond when a visual target is found

June 14, 2018
From looking for Waldo to finding your cellphone on a cluttered kitchen table, we are continuously engaged in visual searches. How does the brain do this? How do we know where to look? How do we know when we've found what ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.